Renvela

Product NDC
58468-0132
11-digit product format
584680132
Labeler code
58468
Product ID
58468-0132_cb4453a2-c47b-4352-839f-f022ac67368e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
SEVELAMER CARBONATE
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Labeler
Genzyme Corporation
Application
NDA022318
Marketing category
NDA
Marketing start
2009-08-12
Substance
SEVELAMER CARBONATE
Active strength
800 mg/1
Pharmacologic classes
Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Renvela
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SEVELAMER CARBONATE800 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii9YCX42I8IU
Rxcui749206, 749210, 861370, 861373, 861375, 861377

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
5085f16b-f856-182d-a646-425b62d3f565Product name620251118
86e7ef73-ca63-701e-e952-6c80aa5122b8Product name920210309

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58468-0132-1Renvela1 in 1 PACKETPOWDER, FOR SUSPENSION147
58468-0132-2Renvela90 in 1 CARTONPOWDER, FOR SUSPENSION9047

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
58468-0132-1EA - Each58468-013253dd274e-b134-404c-a94b-d6f315ff03ee12012-07-24
58468-0132-2EA - Each58468-01320a9035ea-ca87-4f0d-abd1-b02b57e92e4e12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SEVELAMER CARBONATEACTIVE INGREDIENT9YCX42I8IURENVELA (SEVELAMER CARBONATE) TABLET, FILM COATED RENVELA (SEVELAMER CARBONATE) POWDER, FOR SUSPENSION [GENZYME CORPORATION]13
SEVELAMERACTIVE MOIETY941N5DUU5CRENVELA (SEVELAMER CARBONATE) TABLET, FILM COATED RENVELA (SEVELAMER CARBONATE) POWDER, FOR SUSPENSION [GENZYME CORPORATION]13
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61URENVELA (SEVELAMER CARBONATE) TABLET, FILM COATED RENVELA (SEVELAMER CARBONATE) POWDER, FOR SUSPENSION [GENZYME CORPORATION]13
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675RENVELA (SEVELAMER CARBONATE) TABLET, FILM COATED RENVELA (SEVELAMER CARBONATE) POWDER, FOR SUSPENSION [GENZYME CORPORATION]13
HYPROMELLOSE 2910 (15 MPA.S)INACTIVE INGREDIENT36SFW2JZ0WRENVELA (SEVELAMER CARBONATE) TABLET, FILM COATED RENVELA (SEVELAMER CARBONATE) POWDER, FOR SUSPENSION [GENZYME CORPORATION]13
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4RENVELA (SEVELAMER CARBONATE) TABLET, FILM COATED RENVELA (SEVELAMER CARBONATE) POWDER, FOR SUSPENSION [GENZYME CORPORATION]13
PROPYLENE GLYCOL ALGINATEINACTIVE INGREDIENT26CD3J2R0CRENVELA (SEVELAMER CARBONATE) TABLET, FILM COATED RENVELA (SEVELAMER CARBONATE) POWDER, FOR SUSPENSION [GENZYME CORPORATION]13
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XRENVELA (SEVELAMER CARBONATE) TABLET, FILM COATED RENVELA (SEVELAMER CARBONATE) POWDER, FOR SUSPENSION [GENZYME CORPORATION]13
SUCRALOSEINACTIVE INGREDIENT96K6UQ3ZD4RENVELA (SEVELAMER CARBONATE) TABLET, FILM COATED RENVELA (SEVELAMER CARBONATE) POWDER, FOR SUSPENSION [GENZYME CORPORATION]13
ZINC STEARATEINACTIVE INGREDIENTH92E6QA4FVRENVELA (SEVELAMER CARBONATE) TABLET, FILM COATED RENVELA (SEVELAMER CARBONATE) POWDER, FOR SUSPENSION [GENZYME CORPORATION]13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58468-0132RENVELA (SEVELAMER CARBONATE) POWDER, FOR SUSPENSION RENVELA (SEVELAMER CARBONATE) TABLET, FILM COATED [GENZYME CORPORATION]43Current NDC, Legacy NDC, 2 package rows20230926_e6328460-a57b-450b-a48c-6dcd4b476360.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
861377Renvela 0.8 GM Powder for Oral SuspensionPSNe6328460-a57b-450b-a48c-6dcd4b47636047
861373Renvela 2.4 GM Powder for Oral SuspensionPSNe6328460-a57b-450b-a48c-6dcd4b47636047
749210Renvela 800 MG Oral TabletPSNe6328460-a57b-450b-a48c-6dcd4b47636047
861375sevelamer carbonate 0.8 GM Powder for Oral SuspensionPSNe6328460-a57b-450b-a48c-6dcd4b47636047
861370sevelamer carbonate 2.4 GM Powder for Oral SuspensionPSNe6328460-a57b-450b-a48c-6dcd4b47636047
749206sevelamer carbonate 800 MG Oral TabletPSNe6328460-a57b-450b-a48c-6dcd4b47636047
861373sevelamer carbonate 2400 MG Powder for Oral Suspension [Renvela]SBDe6328460-a57b-450b-a48c-6dcd4b47636047
749210sevelamer carbonate 800 MG Oral Tablet [Renvela]SBDe6328460-a57b-450b-a48c-6dcd4b47636047
861377sevelamer carbonate 800 MG Powder for Oral Suspension [Renvela]SBDe6328460-a57b-450b-a48c-6dcd4b47636047
861370sevelamer carbonate 2400 MG Powder for Oral SuspensionSCDe6328460-a57b-450b-a48c-6dcd4b47636047
749206sevelamer carbonate 800 MG Oral TabletSCDe6328460-a57b-450b-a48c-6dcd4b47636047
861375sevelamer carbonate 800 MG Powder for Oral SuspensionSCDe6328460-a57b-450b-a48c-6dcd4b47636047
861377Renvela 0.8 GM Powder for Oral SuspensionSYe6328460-a57b-450b-a48c-6dcd4b47636047
861373Renvela 2.4 GM Powder for Oral SuspensionSYe6328460-a57b-450b-a48c-6dcd4b47636047
861373Renvela 2400 MG Powder for Oral SuspensionSYe6328460-a57b-450b-a48c-6dcd4b47636047
749210Renvela 800 MG Oral TabletSYe6328460-a57b-450b-a48c-6dcd4b47636047
861377Renvela 800 MG Powder for Oral SuspensionSYe6328460-a57b-450b-a48c-6dcd4b47636047
861375sevelamer carbonate 0.8 GM Powder for Oral SuspensionSYe6328460-a57b-450b-a48c-6dcd4b47636047
861370sevelamer carbonate 2.4 GM Powder for Oral SuspensionSYe6328460-a57b-450b-a48c-6dcd4b47636047

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
58468-0132-1584680132011 in 1 PACKETHistorical
58468-0132-25846801320290 PACKET in 1 CARTON (58468-0132-2) / 1 POWDER, FOR SUSPENSION in 1 PACKET (58468-0132-1) 90 packet2009-08-120000-00-00NoNoCurrent